Phenylalanine metabolites as indicators of dietary compliance in children with phenylketonuria

Kimberlee Michals, Mary Lopus, Reuben Matalon

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The data from this study showed that the excretion of three major metabolites of phenylalanine in patients with PKU approach normal values at blood phenylalanine levels less than 5.0 mg/dl. The MANOVA showed statistically significant differences in phenyllactate excretion when blood phenylalanine was greater than 10.0 mg/dl. The PL and total metabolite excretion were significantly correlated to blood phenylalanine in multiple samples taken from two individual subjects. Using data obtained from single patient observations may serve as a means for individualizing the PKU diet to insure low levels of phenylalanine metabolites and thus insure optimal development for patients with PKU.

Original languageEnglish (US)
Pages (from-to)18-23
Number of pages6
JournalBiochemical Medicine and Metabolic Biology
Volume39
Issue number1
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Phenylketonurias
Metabolites
Phenylalanine
Blood
Nutrition
Reference Values
Diet

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Phenylalanine metabolites as indicators of dietary compliance in children with phenylketonuria. / Michals, Kimberlee; Lopus, Mary; Matalon, Reuben.

In: Biochemical Medicine and Metabolic Biology, Vol. 39, No. 1, 1988, p. 18-23.

Research output: Contribution to journalArticle

@article{ffe20ecd11a64f74af5b89417c865d55,
title = "Phenylalanine metabolites as indicators of dietary compliance in children with phenylketonuria",
abstract = "The data from this study showed that the excretion of three major metabolites of phenylalanine in patients with PKU approach normal values at blood phenylalanine levels less than 5.0 mg/dl. The MANOVA showed statistically significant differences in phenyllactate excretion when blood phenylalanine was greater than 10.0 mg/dl. The PL and total metabolite excretion were significantly correlated to blood phenylalanine in multiple samples taken from two individual subjects. Using data obtained from single patient observations may serve as a means for individualizing the PKU diet to insure low levels of phenylalanine metabolites and thus insure optimal development for patients with PKU.",
author = "Kimberlee Michals and Mary Lopus and Reuben Matalon",
year = "1988",
doi = "10.1016/0885-4505(88)90053-9",
language = "English (US)",
volume = "39",
pages = "18--23",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Phenylalanine metabolites as indicators of dietary compliance in children with phenylketonuria

AU - Michals, Kimberlee

AU - Lopus, Mary

AU - Matalon, Reuben

PY - 1988

Y1 - 1988

N2 - The data from this study showed that the excretion of three major metabolites of phenylalanine in patients with PKU approach normal values at blood phenylalanine levels less than 5.0 mg/dl. The MANOVA showed statistically significant differences in phenyllactate excretion when blood phenylalanine was greater than 10.0 mg/dl. The PL and total metabolite excretion were significantly correlated to blood phenylalanine in multiple samples taken from two individual subjects. Using data obtained from single patient observations may serve as a means for individualizing the PKU diet to insure low levels of phenylalanine metabolites and thus insure optimal development for patients with PKU.

AB - The data from this study showed that the excretion of three major metabolites of phenylalanine in patients with PKU approach normal values at blood phenylalanine levels less than 5.0 mg/dl. The MANOVA showed statistically significant differences in phenyllactate excretion when blood phenylalanine was greater than 10.0 mg/dl. The PL and total metabolite excretion were significantly correlated to blood phenylalanine in multiple samples taken from two individual subjects. Using data obtained from single patient observations may serve as a means for individualizing the PKU diet to insure low levels of phenylalanine metabolites and thus insure optimal development for patients with PKU.

UR - http://www.scopus.com/inward/record.url?scp=0023854430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023854430&partnerID=8YFLogxK

U2 - 10.1016/0885-4505(88)90053-9

DO - 10.1016/0885-4505(88)90053-9

M3 - Article

VL - 39

SP - 18

EP - 23

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 1

ER -